Half of mild brain injury patients not recovering after six months, new commission warns
Report published in Lancet Neurology highlights progress and unmet needs for traumatic brain injury prevention, care, and research
Report published in Lancet Neurology highlights progress and unmet needs for traumatic brain injury prevention, care, and research
Millions of people experience traumatic brain injury each year, but more than half of patients who experience mild injury aren’t recovering after six months, a new commission has warned.
In a report published in the Lancet Neurology today, a dedicated Commission by world-leading experts including from the University of Birmingham highlights the advances and persisting and new challenges in prevention, clinical care, and research in Traumatic Brain Injury (TBI).
Among a number of key challenges, the report notes that more than 90% of TBIs are categorized as “mild”, but over 50% of such patients do not fully recover by 6 months after injury. Improving outcome in these patients would be a huge public health benefit. A multidimensional approach to outcome assessment is advocated, including a focus on mental health and post-traumatic stress disorder.
Antonio Belli, Professor of Trauma Neurosurgery in the Institute of Inflammation and Ageing at the University of Birmingham and an author of the commission report said:
“The scale of traumatic brain injury around the world is staggering, with 55 million people affected at an estimated cost of $400bn each year. As a leading cause of injury-related death, this significant report pulls together both the successes in understanding and treating brain injury as well as the task ahead for policy makers, clinicians, and researchers.
“At the University of Birmingham we have a long track record working with clinical partners to better understand brain trauma diagnosis and treatment, and we are proud to have contributed to the commission report.”
The 2022 Commission has been produced by world-leading experts and will be presented to all Participants of the Collaborative European Neurotrauma Effectiveness Research in TBI project (CENTER-TBI) at their meeting on 30th September 2022 in Antwerp, Belgium. This is an update to the first Lancet Neurology Commission on TBI, which was launched at the European Parliament in 2017.
The 2017 Commission set out priorities and recommendations to address the challenges in TBI from the perspectives of policymakers, clinicians, and researchers. Since then, new knowledge has been generated by large observational studies, including CENTER-TBI and other studies conducted under the umbrella of the International Traumatic Brain Injury Research (InTBIR) initiative, designed as a coalition of funding agencies and scientists to advance the care for patients with TBI through collaborative efforts.
For media enquiries please contact Tim Mayo, Press Office, University of Birmingham, tel: +44 (0)7920 405040.
The University of Birmingham is ranked amongst the world’s top 100 institutions. Its work brings people from across the world to Birmingham, including researchers, teachers and more than 6,500 international students from over 150 countries.
The University of Birmingham is a member of Birmingham Health Partners (BHP), a strategic alliance which transcends organisational boundaries to rapidly translate healthcare research findings into new diagnostics, drugs and devices for patients. Birmingham Health Partners is a strategic alliance between five organisations who collaborate to bring healthcare innovations through to clinical application: